Bicyclic Peptide Inhibitors of the Human Urokinase-Type Plasminogen Activator (HUPA)
These bicyclic peptides can detect the urokinase-type plasminogen activator (huPA) and inhibit its cell degeneration action (TRL2/3)
Published: 19th July 2022

Patents
- 102022000012431
IP Status
- Patent application submitted
- Know-how based
Seeking
- Development partner
- Licensing
- University spin out
- Seeking investment